Does the mouse tail vein injection method provide a good model of lung cancer? [version 1; peer review: 2 approved]
Lung cancer drug development requires screening in animal models. We aimed to develop orthotopic models of human non-small lung cancer using A549 and H3122 cells delivered by tail vein injection. This procedure has been used previously for a mouse lung cancer (Lewis lung carcinoma) and as a model of...
Main Authors: | Nensi Shrestha, Zabeen Lateef, Orleans Martey, Abigail R. Bland, Mhairi Nimick, Rhonda Rosengren, John C. Ashton |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-02-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-190/v1 |
Similar Items
-
Investigating the Contribution of Major Drug-Metabolising Enzymes to Possum-Specific Fertility Control
by: Ravneel R. Chand, et al.
Published: (2023-05-01) -
In Vitro Hepatic Assessment of Cineole and Its Derivatives in Common Brushtail Possums (<em>Trichosurus vulpecula</em>) and Rodents
by: Ravneel R. Chand, et al.
Published: (2021-12-01) -
Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer
by: Hannah Palmer, et al.
Published: (2022-04-01) -
Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer
by: Martey O, et al.
Published: (2017-10-01) -
Protocol for tail vein injection in Xenopus tropicalis tadpoles
by: Jeet H. Patel, et al.
Published: (2024-03-01)